日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15, 3448

更正:Hassel 等人,《对 PD-1 靶向免疫检查点抑制剂耐药的黑色素瘤患者的医疗需求和治疗选择》,Cancers 2023, 15, 3448

Hassel, Jessica C; Zimmer, Lisa; Sickmann, Thomas; Eigentler, Thomas K; Meier, Friedegund; Mohr, Peter; Pukrop, Tobias; Roesch, Alexander; Vordermark, Dirk; Wendl, Christina; Gutzmer, Ralf

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

增强 MEK 抑制剂对 BRAF 野生型黑色素瘤的疗效:双硫仑联合治疗的协同作用

Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, Simon Riel, Barbara Schörg, Nicolas Casadei, Manfred Kneilling, Martin Schaller, Lukas Flatz, Boris Macek, Thomas Eigentler, Olaf Rieß, Claus Garbe, Teresa Amaral, Tobias Sinnberg

In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI

转移性癌症患者体内 CD8+ T 细胞的体内成像:首次同时进行 [89Zr]Zr-Df-IAB22M2C PET/MRI 的临床经验

Johannes Schwenck, Dominik Sonanini, Dominik Seyfried, Walter Ehrlichmann, Gabriele Kienzle, Gerald Reischl, Pascal Krezer, Ian Wilson, Ron Korn, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Ferdinand Seith, Andrea Forschner, Thomas Eigentler, Lars Zender, Martin Röcken, Bernd J Pichler, L

Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition

对PD-1靶向免疫检查点抑制剂耐药的黑色素瘤患者的医疗需求和治疗选择

Hassel, Jessica C; Zimmer, Lisa; Sickmann, Thomas; Eigentler, Thomas K; Meier, Friedegund; Mohr, Peter; Pukrop, Tobias; Roesch, Alexander; Vordermark, Dirk; Wendl, Christina; Gutzmer, Ralf

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

剖析未经治疗的人类黑色素瘤脑转移的生态系统

Jana Biermann ,Johannes C Melms ,Amit Dipak Amin ,Yiping Wang ,Lindsay A Caprio ,Alcida Karz ,Somnath Tagore ,Irving Barrera ,Miguel A Ibarra-Arellano ,Massimo Andreatta ,Benjamin T Fullerton ,Kristjan H Gretarsson ,Varun Sahu ,Vaibhav S Mangipudy ,Trang T T Nguyen ,Ajay Nair ,Meri Rogava ,Patricia Ho ,Peter D Koch ,Matei Banu ,Nelson Humala ,Aayushi Mahajan ,Zachary H Walsh ,Shivem B Shah ,Daniel H Vaccaro ,Blake Caldwell ,Michael Mu ,Florian Wünnemann ,Margot Chazotte ,Simon Berhe ,Adrienne M Luoma ,Joseph Driver ,Matthew Ingham ,Shaheer A Khan ,Suthee Rapisuwon ,Craig L Slingluff Jr ,Thomas Eigentler ,Martin Röcken ,Richard Carvajal ,Michael B Atkins ,Michael A Davies ,Albert Agustinus ,Samuel F Bakhoum ,Elham Azizi ,Markus Siegelin ,Chao Lu ,Santiago J Carmona ,Hanina Hibshoosh ,Antoni Ribas ,Peter Canoll ,Jeffrey N Bruce ,Wenya Linda Bi ,Praveen Agrawal ,Denis Schapiro ,Eva Hernando ,Evan Z Macosko ,Fei Chen ,Gary K Schwartz ,Benjamin Izar

Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours

肿瘤免疫控制需要通过干扰素依赖性细胞周期调节通路诱导肿瘤细胞衰老。

Ellen Brenner # ,Barbara F Schörg # ,Fatima Ahmetlić # ,Thomas Wieder ,Franz Joachim Hilke ,Nadine Simon ,Christopher Schroeder ,German Demidov ,Tanja Riedel ,Birgit Fehrenbacher ,Martin Schaller ,Andrea Forschner ,Thomas Eigentler ,Heike Niessner ,Tobias Sinnberg ,Katharina S Böhm ,Nadine Hömberg ,Heidi Braumüller ,Daniel Dauch ,Stefan Zwirner ,Lars Zender ,Dominik Sonanini ,Albert Geishauser ,Jürgen Bauer ,Martin Eichner ,Katja J Jarick ,Andreas Beilhack ,Saskia Biskup ,Dennis Döcker ,Dirk Schadendorf ,Leticia Quintanilla-Martinez ,Bernd J Pichler ,Manfred Kneilling ,Ralph Mocikat ,Martin Röcken

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

转移性黑色素瘤 CTLA-4 和 PD-1 抗体联合治疗中的肿瘤突变负担和循环肿瘤 DNA - 前瞻性生物标志物研究的结果

Andrea Forschner, Florian Battke, Dirk Hadaschik, Martin Schulze, Stephanie Weißgraeber, Chung-Ting Han, Maria Kopp, Maximilian Frick, Bernhard Klumpp, Nicola Tietze, Teresa Amaral, Peter Martus, Tobias Sinnberg, Thomas Eigentler, Ulrike Keim, Claus Garbe, Dennis Döcker, Saskia Biskup

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

外周 PD-1+CD56+ T 细胞频率与 PD-1 阻断下 IV 期黑色素瘤的结果相关

Jonas Bochem, Henning Zelba, Teresa Amaral, Janine Spreuer, Daniel Soffel, Thomas Eigentler, Nikolaus Benjamin Wagner, Ugur Uslu, Patrick Terheyden, Friedegund Meier, Claus Garbe, Graham Pawelec, Benjamin Weide, Kilian Wistuba-Hamprecht

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases

针对 AKT 存活通路的过度激活来克服黑色素瘤脑转移的治疗耐药性

Heike Niessner, Andrea Forschner, Bernhard Klumpp, Jürgen B Honegger, Maria Witte, Antje Bornemann, Reinhard Dummer, Annemarie Adam, Jürgen Bauer, Ghazaleh Tabatabai, Keith Flaherty, Tobias Sinnberg, Daniela Beck, Ulrike Leiter, Cornelia Mauch, Alexander Roesch, Benjamin Weide, Thomas Eigentler, Dir